Holen Sie sich die Stockscreener-App
51.07
2.24%
1.12
Handel nachbörslich:
50.99
-0.08
-0.16%
Schlusskurs vom Vortag:
$49.95
Offen:
$49.87
24-Stunden-Volumen:
1.61M
Relative Volume:
1.00
Marktkapitalisierung:
$7.02B
Einnahmen:
$550.17M
Nettoeinkommen (Verlust:
$201.35M
KGV:
51.07
EPS:
1
Netto-Cashflow:
$232.07M
1W Leistung:
+7.70%
1M Leistung:
-23.59%
6M Leistung:
+0.10%
1J Leistung:
+4.76%
1-Tages-Spanne:
$49.84
$51.39
1-Wochen-Bereich:
$46.04
$51.44
52-Wochen-Spanne:
$46.04
$85.21
Doximity Inc Stock (DOCS) Company Profile
Firmenname
Doximity Inc
Sektor
Branche
Telefon
(650) 549-4330
Adresse
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Vergleichen Sie DOCS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
51.07 | 9.40B | 550.17M | 201.35M | 232.07M | 1.00 |
|
VEEV
Veeva Systems Inc
|
239.95 | 38.75B | 3.08B | 860.33M | 1.33B | 5.1481 |
|
TEM
Tempus Ai Inc
|
76.84 | 13.53B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
105.44 | 8.93B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.98 | 6.98B | 906.14M | -52.62M | 89.62M | -0.3621 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-21 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-10-27 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-10-10 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-10-01 | Herabstufung | Goldman | Neutral → Sell |
| 2025-07-09 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-06-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-02-07 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Neutral |
| 2024-11-14 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Hochstufung | Needham | Hold → Buy |
| 2024-07-18 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-02 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-08-09 | Herabstufung | Needham | Buy → Hold |
| 2023-08-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Eingeleitet | Wells Fargo | Overweight |
| 2022-10-24 | Eingeleitet | Evercore ISI | In-line |
| 2022-10-13 | Eingeleitet | BTIG Research | Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Eingeleitet | Berenberg | Buy |
| 2022-05-18 | Bestätigt | BofA Securities | Neutral |
| 2022-05-18 | Bestätigt | Goldman | Buy |
| 2022-05-18 | Bestätigt | Guggenheim | Buy |
| 2022-05-18 | Bestätigt | Jefferies | Buy |
| 2022-05-18 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Bestätigt | Needham | Buy |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-04 | Eingeleitet | BofA Securities | Neutral |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-11-10 | Bestätigt | Canaccord Genuity | Buy |
| 2021-11-10 | Bestätigt | Goldman | Neutral |
| 2021-11-10 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Bestätigt | Needham | Buy |
| 2021-11-10 | Bestätigt | Piper Sandler | Overweight |
| 2021-08-26 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-19 | Eingeleitet | Goldman | Neutral |
| 2021-07-19 | Eingeleitet | JP Morgan | Overweight |
| 2021-07-19 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-19 | Eingeleitet | Raymond James | Outperform |
| 2021-07-19 | Eingeleitet | SVB Leerink | Outperform |
| 2021-07-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Doximity Inc Aktie (DOCS) Neueste Nachrichten
Universal Beteiligungs und Servicegesellschaft mbH Trims Position in Doximity, Inc. $DOCS - MarketBeat
Doximity, Inc. $DOCS Position Trimmed by Sierra Summit Advisors LLC - MarketBeat
Nomura Asset Management Co. Ltd. Acquires Shares of 7,202 Doximity, Inc. $DOCS - MarketBeat
Nemes Rush Group LLC Invests $1.11 Million in Doximity, Inc. $DOCS - MarketBeat
Franklin Resources Inc. Acquires 1,108,162 Shares of Doximity, Inc. $DOCS - MarketBeat
Prudential PLC Makes New Investment in Doximity, Inc. $DOCS - MarketBeat
Robust Financial Progress and Strategic Adjustments - StocksToTrade
Doximity Stock Surges Amid Strong Earnings and Strategic Outlook - StocksToTrade
Doximity (DOCS) Shines with Strong Q2 Results, Revenue Projections - timothysykes.com
Neo Ivy Capital Management Makes New Investment in Doximity, Inc. $DOCS - MarketBeat
Doximity, Inc. $DOCS Shares Bought by Handelsbanken Fonder AB - MarketBeat
Ensign Peak Advisors Inc Has $42.67 Million Position in Doximity, Inc. $DOCS - MarketBeat
Should Raymond James’ AI-Focused Upgrade Require Action From Doximity (DOCS) Investors? - Yahoo Finance
Doximity Projects Strong Q3 Revenue Guidance Amid Healthcare Shifts - StocksToTrade
Doximity Surges with Strong Q2 Results and Strategic Roadmap - StocksToTrade
Is Doximity’s Recent 24% Pullback a Chance or a Caution for Investors in 2025? - Yahoo Finance
Doximity Stock Climbs: Strong Financial Performance and Analyst Upgrades - timothysykes.com
Doximity’s Revenue Surge and Upbeat Forecasts Propel Stock Forward - timothysykes.com
Why Is Doximity (DOCS) Stock Soaring Today - The Globe and Mail
Doximity’s Unexpected Surge: Analyzing the Latest Performance - StocksToTrade
Doximity rises after Raymond James upgrades to 'strong buy' - TradingView
Doximity upgraded at Raymond James on improving long-term growth visibility - MSN
Raymond James bullish on Doximity saying long term growth trumps seasonal noise - Investing.com Canada
Hims & Hers Accelerates Its Clinician-Led, Platform-Driven Care Model - sharewise.com
EFG Asset Management Americas Corp. Acquires Shares of 26,601 Doximity, Inc. $DOCS - MarketBeat
Raymond James upgrades Doximity stock rating to Strong Buy on compelling valuation - Investing.com
Doximity, Inc. $DOCS Shares Sold by Empowered Funds LLC - MarketBeat
Doximity, SentinelOne, Asure Software, Workday, and Bandwidth Shares Are Falling, What You Need To Know - Finviz
Doximity: Strong Growth but What's Next? - AOL.com
Is Doximity Inc. stock a top pick in earnings seasonJuly 2025 Closing Moves & Weekly High Return Forecasts - newser.com
Can Doximity’s (DOCS) Share Buybacks and Earnings Strength Tell Us More About Its Growth Vision? - simplywall.st
Will Doximity Inc. Class stock outperform benchmarks2025 Market Overview & Expert Curated Trade Ideas - newser.com
Will Doximity Inc. Class stock maintain strong growthQuarterly Performance Summary & Weekly Breakout Stock Alerts - newser.com
How risky is Doximity Inc. Class stock compared to peersJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - newser.com
Will Doximity Inc. Class stock benefit from mergers2025 Price Targets & Weekly High Return Stock Opportunities - newser.com
Why Doximity Inc. Class stock could outperform next yearEarnings Performance Report & Free AI Powered Buy and Sell Recommendations - newser.com
Real time social sentiment graph for Doximity Inc.Market Volume Report & Verified Trade Idea Suggestions - newser.com
Is Doximity Inc. stock overvalued by current metricsTrade Exit Summary & Entry Point Confirmation Alerts - newser.com
Will Doximity Inc. stock recover faster than market2025 Short Interest & Stepwise Trade Signal Guides - newser.com
Stocks to Buy & Sell: Volatility Analysis for Doximity, Marriott, International PaperNews and Statistics - IndexBox
Doximity (NASDAQ:DOCS) Sets New 52-Week LowWhat's Next? - MarketBeat
Chmn Tangney Surrenders 8,005 Of Doximity Inc [DOCS] - TradingView
[Form 4] Doximity, Inc. Insider Trading Activity - Stock Titan
Finanzdaten der Doximity Inc-Aktie (DOCS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):